R Golouh

Author PubWeight™ 33.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. J Clin Oncol 1992 3.17
2 Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group. J Clin Oncol 1992 2.00
3 The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy. Cancer 1998 1.40
4 Hepatoblastoma in fine needle aspirates. Acta Cytol 1996 1.38
5 Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Cancer 1986 1.25
6 Causes of microsatellite instability in colorectal tumors: implications for hereditary non-polyposis colorectal cancer screening. Cancer Genet Cytogenet 2001 1.21
7 Prognostic importance of thymidylate synthase expression in early breast cancer. J Clin Oncol 1997 1.08
8 Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer 1999 1.05
9 Secretory breast carcinoma in a man diagnosed by fine needle aspiration biopsy. A case report. Acta Cytol 1994 1.02
10 Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors. Clin Cancer Res 1999 0.94
11 Stefins and lysosomal cathepsins B, L and D in human breast carcinoma. Int J Cancer 1992 0.93
12 Adenomyoepithelioma of the breast diagnosed by fine needle aspiration (FNA) biopsy; a case report. Cytopathology 1997 0.90
13 Anaplastic thyroid carcinoma in fine needle aspirates. Acta Cytol 1996 0.88
14 Effect of primary treatment on survival in anaplastic thyroid carcinoma. Eur J Surg Oncol 2001 0.87
15 Naturally occurring mutations and functional polymorphisms in multidrug resistance 1 gene: correlation with microsatellite instability and lymphoid infiltration in colorectal cancers. J Med Genet 2002 0.86
16 Papillary thyroid carcinoma with exuberant nodular fasciitis-like stroma in a fine needle aspirate. A case report. Acta Cytol 1999 0.84
17 Human papillomavirus DNA in oral squamous cell carcinomas and normal oral mucosa. Acta Virol 2003 0.83
18 Amphicrine--composite calcitonin and mucin-producing--carcinoma of the thyroid. Ultrastruct Pathol 1985 0.82
19 Added value of blue dye in sentinel node biopsy for breast cancer. J Exp Clin Cancer Res 2003 0.82
20 Cathepsin B and its inhibitor stefin A in brain tumors. Pflugers Arch 2000 0.82
21 Differential diagnosis of the pleomorphic aspiration biopsy sample of nonepithelial lesions. Diagn Cytopathol 1986 0.82
22 Cystatins and cathepsins in breast carcinoma. Biol Chem Hoppe Seyler 1992 0.81
23 Immunochemical localisation of cathepsin S, cathepsin L and MHC class II-associated p41 isoform of invariant chain in human lymph node tissue. Biol Chem 2001 0.80
24 Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer. Ann Oncol 2009 0.80
25 Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. Ann Oncol 2008 0.80
26 Prognostic significance of PU.1 in follicular lymphoma. J Pathol 2006 0.79
27 Familial occurrence of infantile myofibromatosis. Cancer 1992 0.79
28 Primary bone sarcoma with rhabdomyosarcomatous component. Pathol Res Pract 1994 0.78
29 Abdominal lymphoma with alpha-heavy chain disease. Isr J Med Sci 1975 0.78
30 Evaluation of microsatellite markers for efficient assessment of high microsatellite instabile colorectal tumors. Pflugers Arch 2000 0.78
31 Medullary carcinoma of the thyroid with serotonin production and carcinoid-like syndrome. Eur J Surg Oncol 2001 0.77
32 Prognostic factors in follicular carcinoma of the thyroid--a multivariate survival analysis. Eur J Surg Oncol 1999 0.77
33 The role of P-glycoprotein (MDR1) polymorphisms and mutations in colorectal cancer. Pflugers Arch 2001 0.76
34 Immunohistochemical localization of group II phospholipase A2 in the tumours and mucosa of the colon and rectum. Eur J Surg Oncol 2001 0.76
35 Characterization of malignant thyroid gland tissue by magnetic resonance methods. Br J Cancer 1974 0.75
36 Germinal center in rat lymphatic tissues after the administration of L-asparaginase. Adv Exp Med Biol 1973 0.75
37 Medullary carcinoma of the thyroid glad: diagnostic cytopathological characteristics. Pathologica 1998 0.75
38 Transfection of mammalian cells by the methods of receptor mediated gene transfer and particle bombardment. J Exp Clin Cancer Res 1999 0.75
39 Marginal vacuoles in fine-needle aspirates of follicular thyroid carcinoma. Diagn Cytopathol 1996 0.75
40 Hydrolysis profiles of formalin fixed paraffin-embedded tumors based on IOD (integrated optical density) and nuclear texture feature measurements. Anal Cell Pathol 1999 0.75
41 Anti-tumor effect of tumor necrosis factor combined with electrotherapy on mouse sarcoma. Anticancer Drugs 1994 0.75
42 Ovarian cancer in children and adolescents: a review of 15 cases. Med Pediatr Oncol 1977 0.75
43 Computer-assisted scanning in evaluation of 67Ga-citrate uptake in thyroid disease. J Nucl Med 1974 0.75
44 L-Asparaginase: effect on 7S gamma globulin extents and germinal centers in spleen and lymph-nodes. Acta Vitaminol Enzymol 1976 0.75
45 Comparative accumulation of 99mTc and 131I in thyroid nodules: case report. J Nucl Med 1977 0.75
46 Tissue damage after fine needle aspiration biopsy. Acta Cytol 1992 0.75
47 Magnetic resonance study of freezing damage development in rat liver tissue. Cryobiology 1978 0.75
48 Decreased cortisol secretion by adrenal glands perfused with the P-glycoprotein inhibitor valspodar and mitotane or doxorubicin. Anticancer Drugs 2000 0.75
49 A novel Q562X mutation identified in the hMLH1 gene in a Slovenian patient with hereditary nonpolyposis colorectal cancer. Hum Hered 2000 0.75
50 [Castleman's disease]. Plucne Bolesti 1988 0.75